48 related articles for article (PubMed ID: 9679981)
1. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens.
Woods KV; El-Naggar A; Clayman GL; Grimm EA
Cancer Res; 1998 Jul; 58(14):3132-41. PubMed ID: 9679981
[TBL] [Abstract][Full Text] [Related]
2. Cytokines IL-1 alpha, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon gamma.
Thomas GR; Chen Z; Leukinova E; Van Waes C; Wen J
Cancer Immunol Immunother; 2004 Jan; 53(1):33-40. PubMed ID: 14551747
[TBL] [Abstract][Full Text] [Related]
3. PD-L2 based immune signature confers poor prognosis in HNSCC.
Qiao Y; Liu C; Zhang X; Zhou Q; Li Y; Xu Y; Gao Z; Xu Y; Kong L; Yang A; Mei M; Ren Y; Wang X; Zhou X
Oncoimmunology; 2021; 10(1):1947569. PubMed ID: 34377590
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Babiuch K; Kuśnierz-Cabala B; Kęsek B; Okoń K; Darczuk D; Chomyszyn-Gajewska M
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245251
[TBL] [Abstract][Full Text] [Related]
5. The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
Lin CM; Lin LW; Chen YW; Ye YL
Cancer Immunol Immunother; 2020 Apr; 69(4):549-558. PubMed ID: 31970439
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy.
Schuster C; Akslen LA; Stokowy T; Straume O
J Pathol Clin Res; 2019 Jan; 5(1):53-62. PubMed ID: 30225999
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ and other serum cytokines in head and neck squamous cell carcinomas.
Bussu F; Graziani C; Gallus R; Cittadini A; Galli J; DE Corso E; DI Cintio G; Corbi M; Almadori G; Boninsegna A; Paludetti G; Sgambato A
Acta Otorhinolaryngol Ital; 2018 Apr; 38(2):94-102. PubMed ID: 29967556
[TBL] [Abstract][Full Text] [Related]
8. HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.
de Medeiros MC; Banerjee R; Liu M; Anovazzi G; D'Silva NJ; Junior CR
Oncotarget; 2017 Sep; 8(37):60860-60874. PubMed ID: 28977830
[TBL] [Abstract][Full Text] [Related]
9. Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma.
Liu S; Ye D; Wang T; Guo W; Song H; Liao Y; Xu D; Zhu H; Zhang Z; Deng J
Cancer Cell Int; 2017; 17():34. PubMed ID: 28270740
[TBL] [Abstract][Full Text] [Related]
10. Areca nut components stimulate ADAM17, IL-1α, PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling.
Chang MC; Chan CP; Chen YJ; Hsien HC; Chang YC; Yeung SY; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
Oncotarget; 2016 Mar; 7(13):16879-94. PubMed ID: 26919242
[TBL] [Abstract][Full Text] [Related]
11. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma.
León X; Bothe C; García J; Parreño M; Alcolea S; Quer M; Vila L; Camacho M
Oncotarget; 2015 Nov; 6(35):37398-409. PubMed ID: 26460957
[TBL] [Abstract][Full Text] [Related]
12. Identification of mutations in the PYRIN-containing NLR genes (NLRP) in Head and Neck Squamous Cell Carcinoma.
Lei Y; Lui VW; Grandis JR; Egloff AM
PLoS One; 2014; 9(1):e85619. PubMed ID: 24465623
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer.
Prasad G; McCullough M
Int J Dent; 2013; 2013():813756. PubMed ID: 24376459
[TBL] [Abstract][Full Text] [Related]
14. p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia.
Saiz-Ladera C; Lara MF; Garín M; Ruiz S; Santos M; Lorz C; García-Escudero R; Martínez-Fernández M; Bravo A; Fernández-Capetillo O; Segrelles C; Paramio JM
Oncogene; 2014 Sep; 33(37):4599-4612. PubMed ID: 24121270
[TBL] [Abstract][Full Text] [Related]
15. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.
Koontongkaew S
J Cancer; 2013; 4(1):66-83. PubMed ID: 23386906
[TBL] [Abstract][Full Text] [Related]
16. The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival.
Millrud CR; Månsson Kvarnhammar A; Uddman R; Björnsson S; Riesbeck K; Cardell LO
PLoS One; 2012; 7(12):e51120. PubMed ID: 23251433
[TBL] [Abstract][Full Text] [Related]
17. Ah receptor antagonism represses head and neck tumor cell aggressive phenotype.
DiNatale BC; Smith K; John K; Krishnegowda G; Amin SG; Perdew GH
Mol Cancer Res; 2012 Oct; 10(10):1369-79. PubMed ID: 22912337
[TBL] [Abstract][Full Text] [Related]
18. Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients.
Machon C; Thezenas S; Dupuy AM; Assenat E; Michel F; Mas E; Senesse P; Cristol JP
Support Care Cancer; 2012 Dec; 20(12):3129-35. PubMed ID: 22453793
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
Leibowitz MS; Andrade Filho PA; Ferrone S; Ferris RL
Cancer Immunol Immunother; 2011 Apr; 60(4):525-35. PubMed ID: 21207025
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
